Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review.

Nuffield Department of Obstetrics and Gynecology, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Obstetrics and Gynecology (Impact Factor: 4.8). 02/2007; 109(1):168-80. DOI: 10.1097/01.AOG.0000249609.04831.7c
Source: PubMed

ABSTRACT To evaluate claims that elevated soluble fms-like tyrosine kinase-1 receptor (sFlt-1) and decreased placental growth factor predict preeclampsia.
MEDLINE (1966-March 2006), EMBASE (1980-June 2006), POPLINE (1980-June 2006), CINAHL (1982-June 2006), and LILACS (1982-June 2006) were searched, and experts contacted.
Studies identified and included were those reporting blood and urine levels of sFlt-1 or placental growth factor obtained before gestational week 30 or overt preeclampsia.
Ten of 184 available studies analyzing sFlt-1 and 14 of 319 studies analyzing placental growth factor were included in this review. There was considerable interreport heterogeneity in methodology and results for sFlt-1 measured before gestational week 25. After week 25 placental growth factor and sFlt-1 levels varied consistently between the normal pregnancy group and women destined to develop preeclampsia, achieving significance in women who developed severe preeclampsia.
Third-trimester increases in sFlt-1 and decreases in placental growth factor levels are associated with preeclampsia, specifically severe disease, based on retrospective data. The evidence is insufficient to recommend these markers to be used for screening, and prospective studies employing rigorous laboratory and study design criteria are needed to determine the clinical usefulness of these tests.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pregnancy encompasses substantial changes in vascular function in order to accommodate dramatic increases in blood volume and uteroplacental blood flow to the growing fetus. Despite increased hemodynamics, decreased peripheral resistance results in a reduction in mean arterial blood pressure. Vascular tone, and hence peripheral resistance, is determined by a delicate balance of constrictor and dilator capacities. In the normal physiological response to pregnancy, EDH has been shown to be a major contributor; both endothelial-derived hyperpolarisation (EDH) and nitric oxide (NO) are predominantly involved in providing an increased vascular capacity for vasodilation. The ability of EDH and NO to adequately accommodate increased blood volume is tested in pathological states such as placental insufficiency or diabetes and both EDH and NO-dependent mechanisms appear to be impacted in these situations. Pregnancy complications also impact on the cardiovascular health of the offspring. In adult offspring born from complicated pregnancies, the data suggest that EDH mechanisms are largely maintained while NO is commonly reduced. A diversity of EDH mechanisms may be useful in providing many targets for potential therapeutic avenues for compromised pregnancies; however, further research delineating the mechanisms of EDH and the interactions of NO and EDH, in normal and pathological pregnancies is required.
    Journal of cardiovascular pharmacology 11/2012; · 2.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of the present study was to elucidate the possible association between hyperandrogenemia and preeclampsia by analysing serum testosterone (T) in pregnant women with a specific liquid chromatography tandem mass spectrometric (LC-MS/MS) method. Serum levels of T, sex hormone binding globulin (SHBG) and testosterone/sex hormone binding globulin-ratio (T/SHBG-ratio) were determined during the first and second trimester in pregnancy from 91 pregnant women who later developed preeclampsia and from 182 healthy controls. There were no significant differences in serum T levels measured by LC-MS/MS between the patients and matched controls. The fetal gender had no influence on serum hormone levels or differences between the groups. Nor were there any significant differences in individual changes of hormones between the two sample taking periods. The results were unaffected by the matching of maternal body mass index (BMI) or other interfering factors such as parity, maternal age at the sample collection time and maternal smoking in multiple regression analyses. The concentrations of serum T, SHBG and the T/SHBG-ratio in early pregnancy do not predict the development of preeclampsia.
    Scandinavian journal of clinical and laboratory investigation 05/2011; 71(5):413-8. · 1.38 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pre-eclampsia complicates around 5% of pregnancies and hypertensive disorders of pregnancy are responsible for over 60,000 maternal deaths worldwide annually. Identifying women with pre-eclampsia is a major goal of antenatal care in order to target increased surveillance, allow stabilizing therapies to be implemented and to enable timely delivery. Current risk assessment is based on clinical history, imperfect assessment of clinical signs (e.g., hypertension and proteinuria) and nonspecific biochemical markers, all of which are subject to considerable error. This is further confounded by underlying maternal disease such as chronic hypertension or renal pathology. Angiogenic factors reflect the underlying pathophysiology of pre-eclampsia and there is emerging evidence that they can now be used for more accurate risk assessment. The most promising of these factors include placental growth factor and soluble fms-like tyrosine kinase-1. Used at point of care, these can accurately discriminate true disease in suspected cases and subsequent need for delivery.
    Expert Review of Molecular Diagnostics 04/2014; · 4.09 Impact Factor

Full-text (2 Sources)

Available from
Jun 11, 2014